Arcutis Biotherapeutics, Inc.
ARQT
Kedudukan dalam Saham
#4003
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Harga Saham
$32.29
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$4.06B
Perubahan (1 hari)
12.02%
Perubahan (1 tahun)
54.62%
Negara
US
Perdagangan Arcutis Biotherapeutics, Inc. (ARQT)
Kategori
Healthcare
Nisbah P/S bagi Arcutis Biotherapeutics, Inc. (ARQT)
Nisbah P/S pada October 2026 TTM: 7.15
Menurut laporan kewangan dan harga saham terkini Arcutis Biotherapeutics, Inc., nisbah P/S semasa (TTM) ialah 7.15. Pada akhir 2023, nisbah P/S syarikat ialah 3.76.
Sejarah nisbah P/S untuk Arcutis Biotherapeutics, Inc. dari 2017 hingga 2026
Nisbah P/S pada akhir setiap tahun
| Tahun | Nisbah P/S | Ubah |
|---|---|---|
| 2026 (TTM) | 7.15 | -16.55% |
| 2024 | 8.57 | 128.27% |
| 2023 | 3.76 | -98.30% |
| 2022 | 220.96 | 0.00% |
| 2021 | 0.00 | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
Nisbah P/S untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/S | Perbezaan Nisbah P/S | Negara |
|---|---|---|---|
| 10.02 | 40.14% |
US
|
|
| 40.55 | 467.01% |
US
|
|
| 3.96 | -44.61% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | 41.87% |
NL
|
